Michelle A. Benjamin, PA

Michelle Benjamin practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Michelle Benjamin's NPI, 1558354878, was assigned on August 23, 2005. Michelle Benjamin holds Texas license PA12456.

Michelle Benjamin's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Michelle Benjamin's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service. Dmand AI also links Michelle Benjamin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michelle Benjamin practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Michelle Benjamin's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Michelle Benjamin is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Michelle Benjamin's licenses on file in 3 states: Texas, Florida and Wisconsin.

Dmand AI lists enlarged prostate and UTI among the conditions Michelle Benjamin treats.

CMS data shows 153 Medicare services from Michelle Benjamin across 1 procedure code in 2024, all of them office visits, for 148 Medicare patients. Medicare paid $6,074 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Michelle Benjamin in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michelle Benjamin's median patient age at 70, with 10% women.

In 2024, Michelle Benjamin wrote 159 Medicare Part D claims for 76 patients. 97% of them were for generic drugs. CMS names the drug for 99 of them, across 2 drugs with 11 or more claims each, at $813 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Michelle Benjamin for performance year 2024, reported as part of a group. Michelle Benjamin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michelle Benjamin as offering telehealth.

CMS Open Payments shows 8 general payments to Michelle Benjamin from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $153.